Laboratory Informatics
Op-Ed: The COVID-19 Impact on Global Pathology
- Anatomic Pathology
- Business
- Clinical Laboratories
- Clinical Pathology
- Current Affairs
- Data Management
- Device Manufacturers
- Digital Pathology News
- General Healthcare News
- Image Analysis
- Informatics
- Laboratory Informatics
- Laboratory Information Systems
- Laboratory Management & Operations
- Marketing
- New Digital Imaging Technologies
- Pathology News
- TeleHealth
- Vendor products
- Whole slide
By Nicholas Chan, Director of Digital Pathology at Motic COVID-19 is here to stay. What can we do about it? It’s become increasingly likely over the last several months, with the world grinding to a halt from this pandemic, that COVID-19...
FDA’s Enforcement Discretion Allowing Use of ImageScope DX Viewing Software for Remote Diagnosis During COVID-19 Emergency Your safety is very important to us at Leica Biosystems. We are pleased to inform you that Aperio ImageScope DX with...
7 research projects (investigating cancer, neurodegenerative, and liver diseases) spanning 4 countries (Norway, Finland, the Netherlands, and the US) are all currently underway in the aiForward program. Created and run by Aiforia, the aiForward...
Linköping, Sweden and Shelton, CT – International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has received a 510(k) clearance by the US Food & Drug Administration (FDA). The clearance applies for Sectra Digital...
OncoLens Offering Virtual Tumor Board Platform at No Cost
- Advocacy
- Anatomic Pathology
- Clinical Laboratories
- Clinical Pathology
- Cloud Computing
- Conferences
- Current Affairs
- Data Management
- Digital Pathology News
- Education
- General Healthcare News
- Health Technology Collaboration
- Informatics
- Laboratory Informatics
- Medical Research
- Pathology News
- Science
- Storage
- TeleHealth
- Tissue banking
- Vendor products
- Web/Tech
- Whole slide
In response to COVID-19, we are offering the OncoLens Virtual Tumor Board module at no cost, through the end of May, 2020. The module enables cancer care teams to meet completely virtually, in real time, to discuss treatment options for their...
Leica Biosystems Receives FDA’s Enforcement Discretion for Us...
- Advocacy
- Anatomic Pathology
- Clinical Laboratories
- Clinical Pathology
- Cloud Computing
- Current Affairs
- Data Management
- Device Manufacturers
- Digital Pathology News
- Education
- General Healthcare News
- Government
- Health Technology Collaboration
- Informatics
- Laboratory Compliance
- Laboratory Informatics
- Laboratory Management & Operations
- Pathology News
- TeleHealth
- Vendor products
- Web/Tech
- Whole slide
Leica Biosystems, the global leader in pathology workflow solutions, announced it has received notification from the U.S. Food & Drug Administration (FDA) that its Aperio ImageScope DX Viewer with images acquired on the Aperio AT2 DX...































